Zhu Zhixing, Lian Xihua, Bhatia Madhav
Department of Pathology and Biomedical Science, University of Otago, Christchurch 8140, New Zealand.
Department of Internal Medicine (Pulmonary and Critical Care Medicine), The Second Clinical Medical School of Fujian Medical University, Quanzhou 362002, China.
Antioxidants (Basel). 2022 Oct 31;11(11):2162. doi: 10.3390/antiox11112162.
Hydrogen sulfide (HS) has been acknowledged as a novel gaseous mediator. The metabolism of HS in mammals is tightly controlled and is mainly achieved by many physiological reactions catalyzed by a suite of enzymes. Although the precise actions of HS in regulating programmed cell death, oxidative stress and inflammation are yet to be fully understood, it is becoming increasingly clear that HS is extensively involved in these crucial processes. Since programmed cell death, oxidative stress and inflammation have been demonstrated as three important mechanisms participating in the pathogenesis of various pulmonary diseases, it can be inferred that aberrant HS metabolism also functions as a critical contributor to pulmonary diseases, which has also been extensively investigated. In the meantime, substantial attention has been paid to developing therapeutic approaches targeting HS for pulmonary diseases. In this review, we summarize the cutting-edge knowledge on the metabolism of HS and the relevance of HS to programmed cell death, oxidative stress and inflammation. We also provide an update on the crucial roles played by HS in the pathogenesis of several pulmonary diseases. Finally, we discuss the perspective on targeting HS metabolism in the treatment of pulmonary diseases.
硫化氢(HS)已被公认为一种新型气体介质。哺乳动物体内HS的代谢受到严格调控,主要通过一系列酶催化的多种生理反应来实现。尽管HS在调节程序性细胞死亡、氧化应激和炎症方面的确切作用尚未完全明确,但越来越清楚的是,HS广泛参与这些关键过程。由于程序性细胞死亡、氧化应激和炎症已被证明是参与各种肺部疾病发病机制的三个重要机制,可以推断,HS代谢异常也是肺部疾病的关键促成因素,这一点也已得到广泛研究。与此同时,针对肺部疾病开发靶向HS的治疗方法已受到广泛关注。在本综述中,我们总结了关于HS代谢的前沿知识以及HS与程序性细胞死亡、氧化应激和炎症的相关性。我们还提供了HS在几种肺部疾病发病机制中所起关键作用的最新信息。最后,我们讨论了针对HS代谢治疗肺部疾病的前景。